SciCombinator

Discover the most talked about and latest scientific content & concepts.

AH Zaky, R Bakry, MI El-sayed, MA Elwanis and O Nabih
Abstract
NOVELTY AND IMPACT: This first study compares the survival of HCV-positive DLBCL treated with and without rituximab which showed in toxicity and the outcome.
Tweets*
1
Facebook likes*
0
Reddit*
0
News coverage*
0
Blogs*
0
SC clicks
1
Concepts
B cell, BCL6, B-cell lymphoma, Rituximab, Types of cancer, Diffuse large B cell lymphoma, Lymphoma
MeSH headings
-
comments powered by Disqus

* Data courtesy of Altmetric.com